Acceptability and Tolerability of Insty in children with ENT pathologies
It has been clinically proven that Insty is safe and effective for children of 1 year of age and older as refrigerant, anti-inflammatory and expectorant formulation for treatment of non-complicated ARVI, tracheitis, rhinitis and pharyngitis. The overall efficacy rate was 100%.
Conducted by Public Health Department of Almaty in Pediatric City Polyclinic by Head Physician N. Odarchenko in 2004.
Role of Insty in treating patients with ARVI accompanied by pharyngitis, rhinitis, cough syndrome or sore throat symptoms
It has been clinically proven that Insty is safe and effective in treating patients with acute catarrhal diseases accompanied by fever with clinical signs of upper respiratory inflammation (pharyngitis, traacheitis, laryngitis).
Conducted in central district of Moscow by Professor A.M. Togoev in 2004.
Significance of Insty in curing patients with non-severe ARVI accompanied by acute rhinitis, laryngotracheitis and tracheitis
It has been clinically proven that Insty is safe and effective for use of monotherapy in non-severe ARVI accompanied by acute rhinitis, laryngotracheitis, tracheitis with subfebrile temperatures and no purulent discharge.
Conducted by Russian Academy of Medical Sciences by Professor V.G. Kukes in Moscow in 2003.
